MYL9 and neoplasm: Fig. 6, the downregulated gene set (e.g., MYL9, ABCG2, SORBS1) was consistently suppressed in 17 cancer types, suggesting a potential tumor-suppressive-like role and involvement in shared oncogenic processes.